Haleon plc (HLN)
USD 9.71
(-2.02%)
USD 9.71
(-2.02%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.99 Billion GBP | 37.26% |
| 2022 | 1.82 Billion GBP | 11.42% |
| 2021 | 1.63 Billion GBP | 2.5% |
| 2020 | 1.59 Billion GBP | 78.15% |
| 2019 | 897 Million GBP | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 662 Million GBP | 144.28% |
| 2024 Q2 | 496 Million GBP | -25.08% |
| 2023 Q4 | 271 Million GBP | -53.6% |
| 2023 FY | 2.5 Billion GBP | 37.26% |
| 2023 Q3 | 584 Million GBP | 13.62% |
| 2023 Q2 | 514 Million GBP | -18.02% |
| 2023 Q1 | 627 Million GBP | 7.92% |
| 2022 Q3 | 569 Million GBP | 31.11% |
| 2022 Q1 | 466 Million GBP | 175.74% |
| 2022 Q4 | 581 Million GBP | 2.11% |
| 2022 FY | 1.82 Billion GBP | 11.42% |
| 2022 Q2 | 434 Million GBP | -6.87% |
| 2021 Q2 | 393 Million GBP | 15.93% |
| 2021 Q3 | 507 Million GBP | 29.01% |
| 2021 Q4 | 169 Million GBP | -66.67% |
| 2021 Q1 | 339 Million GBP | 0.0% |
| 2021 FY | 1.63 Billion GBP | 2.5% |
| 2020 FY | 1.59 Billion GBP | 78.15% |
| 2019 FY | 897 Million GBP | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 204.37 Million USD | -876.641% |
| Bausch Health Companies Inc. | 963 Million USD | -107.269% |
| Catalent, Inc. | -749 Million USD | 366.489% |
| Emergent BioSolutions Inc. | -726.4 Million USD | 374.78% |
| Elanco Animal Health Incorporated | 326 Million USD | -512.27% |
| Perrigo Company plc | 151.9 Million USD | -1214.022% |
| Teva Pharmaceutical Industries Limited | 433 Million USD | -360.97% |
| Zoetis Inc. | 3.06 Billion USD | 34.963% |